Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Treasury Shares (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Treasury Shares for 9 consecutive years, with $798422.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 239.0% to $798422.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $798422.0 through Dec 2025, up 239.0% year-over-year, with the annual reading at $798422.0 for FY2025, 239.0% up from the prior year.
  • Treasury Shares for Q4 2025 was $798422.0 at Madrigal Pharmaceuticals, up from $306982.0 in the prior quarter.
  • The five-year high for Treasury Shares was $798422.0 in Q4 2025, with the low at $96485.0 in Q1 2025.
  • Average Treasury Shares over 3 years is $381593.2, with a median of $309374.5 recorded in 2023.
  • Peak annual rise in Treasury Shares hit 239.0% in 2025, while the deepest fall reached 81.82% in 2025.
  • Over 3 years, Treasury Shares stood at $376117.0 in 2023, then crashed by 37.38% to $235520.0 in 2024, then soared by 239.0% to $798422.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $798422.0, $306982.0, and $757263.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.